Last updated on June 2020

Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy


Brief description of study

This is an open-label, multi-centre, umbrella Phase II study in patients with metastatic NSCLC who have progressed on an anti-PD-1/PD-L1 containing therapy. This study is modular in design, allowing initial assessment of the efficacy, safety, and tolerability of multiple treatment arms.

Detailed Study Description

This is an open-label, multi-centre, umbrella Phase II study in patients with metastatic non-small cell lung cancer (NSCLC) who have progressed on an anti-programmed cell death-1/anti-programmed cell death ligand 1 (anti-PD-1/PD-L1) containing therapy. This study is modular in design, consisting of a number of treatment cohorts, allowing evaluation of the efficacy, safety, and tolerability of multiple treatment arms. There is currently no established therapy for patients who have received immune checkpoint inhibitors and platinum-doublet therapies, and novel treatments are urgently needed.

This protocol has a modular design, with the potential for future treatment arms to be added via protocol amendment.

Clinical Study Identifier: NCT03334617

Find a site near you

Start Over

Research Site

Duarte, CA United States
  Connect »

Research Site

Fullerton, CA United States
  Connect »

Research Site

La Jolla, CA United States
  Connect »

Research Site

Los Angeles, CA United States
  Connect »

Research Site

Baltimore, MD United States
  Connect »

Research Site

Boston, MA United States
  Connect »

Research Site

Saint Louis, MO United States
  Connect »

Research Site

New York, NY United States
  Connect »

Research Site

Philadelphia, PA United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Houston, TX United States
  Connect »

Research Site

Innsbruck, Austria
  Connect »

Research Site

Salzburg, Austria
  Connect »

Research Site

Edmonton, AB Canada
  Connect »

Research Site

Brampton, ON Canada
  Connect »

Research Site

Ottawa, ON Canada
  Connect »

Research Site

Toronto, ON Canada
  Connect »

Research Site

Montreal, QC Canada
  Connect »

Research Site

Bordeaux Cedex, France
  Connect »

Research Site

Nantes Cedex 1, France
  Connect »

Research Site

Villejuif, France
  Connect »

Research Site

Frankfurt, Germany
  Connect »

Research Site

Grosshansdorf, Germany
  Connect »

Research Site

Heidelberg, Germany
  Connect »

Research Site

Kfar Saba, Israel
  Connect »

Research Site

Petach-Tikva, Israel
  Connect »

Research Site

Ramat Gan, Israel
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Tampa, FL United States
  Connect »

Research Site

Bordeaux, France
  Connect »

Research Site

Petah Tikva, Israel
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.